➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Colorcon

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 9,968,606

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,968,606
Title:Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof
Abstract: The invention provides novel chemical compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
Inventor(s): Huang; Chaoran (Auburndale, MA), Cheng; Changfu (Northborough, MA)
Assignee: NeuForm Pharmaceuticals, Inc. (Auburndale, MA)
Application Number:15/599,415
Patent Claims:see list of patent claims

Details for Patent 9,968,606

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial NeuForm Pharmaceuticals, Inc. (Auburndale, MA) 2035-12-27 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial NeuForm Pharmaceuticals, Inc. (Auburndale, MA) 2035-12-27 RX Orphan search
Eli Lilly And Co CYRAMZA ramucirumab INJECTABLE;INJECTION 125477 001 2014-04-21   Start Trial NeuForm Pharmaceuticals, Inc. (Auburndale, MA) 2035-12-27 RX search
Eli Lilly And Co CYRAMZA ramucirumab INJECTABLE;INJECTION 125477 002 2014-04-21   Start Trial NeuForm Pharmaceuticals, Inc. (Auburndale, MA) 2035-12-27 RX search
Merck Sharp Dohme KEYTRUDA pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 001 2014-09-04   Start Trial NeuForm Pharmaceuticals, Inc. (Auburndale, MA) 2035-12-27 RX Orphan search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04   Start Trial NeuForm Pharmaceuticals, Inc. (Auburndale, MA) 2035-12-27 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04   Start Trial NeuForm Pharmaceuticals, Inc. (Auburndale, MA) 2035-12-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Boehringer Ingelheim
AstraZeneca
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.